(Q33334325)

25 July 2017

title

Granulocyte-macrophage colony-stimulating factor is not responsible for residual thrombopoiesis in mpl null mice (English)

1 reference

25 July 2017

1 reference

Scott CL

1

1 reference

25 July 2017

Robb L

2

1 reference

25 July 2017

Mansfield R

3

1 reference

25 July 2017

Alexander WS

4

1 reference

25 July 2017

Begley CG

5

1 reference

25 July 2017

publication date

1 September 2000

1 reference

25 July 2017

published in

Experimental Hematology

1 reference

25 July 2017

volume

28

1 reference

25 July 2017

issue

9

1 reference

25 July 2017

page(s)

1001-1007

1 reference

Thrombocytopenia in c-mpl-deficient mice

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Adult Mice With Targeted Mutation of the Interleukin-11 Receptor (IL11Ra) Display Normal Hematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Mouse models of human genetic disease: which mouse is more like a man?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Effects of genetic background on tumorigenesis in p53-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900504-X

7 January 2021

10.1016/S0301-472X(00)00504-X

Identifiers

DOI

1 reference

25 July 2017

1 reference